Drug intelligence / Profile preview

Dangfei Liganning

Development stage
Unknown
Lead developer
Sichuan Meidakang Pharmaceutical
Administration
Oral
01

Overview

Dangfei Liganning (also known as Dangfei Liganning Capsule) is a traditional Chinese patent medicine composed of extracts from *Silybum marianum* (milk thistle) and *Swertia pseudochinensis* (Dangyao). It is primarily developed and manufactured by Sichuan Meidakang Pharmaceutical. Dangfei Liganning is indicated for clearing damp-heat, benefiting the liver, and relieving jaundice. It is widely used in China for the treatment of acute icteric hepatitis, chronic hepatitis, and nonalcoholic fatty liver disease (NAFLD) / metabolic dysfunction-associated fatty liver disease (MAFLD). Mechanistically, it has been shown to protect hepatocyte membranes, reduce transaminase levels (ALT/AST), and alleviate hepatic lipid accumulation, potentially by blocking the LXRα-SREBP-1-FAS signaling pathway and regulating AMPK/mTOR-mediated lipophagy.

Brand names
Meidakang
Other names
Dangfei Liganning CapsuleDangfei Liganning Capsules当飞利肝宁胶囊当飞利肝宁Dangfei Liganning Jiaonang
02

Targets

mTOR (Mammalian target of rapamycin kinase)AMPK (Adenosine monophosphate–activated protein kinase)NR1H3 (Liver X receptor beta)

Beyond the preview

Go deeper on Dangfei Liganning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dangfei Liganning.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call